C. Gambacorti-passerini: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Chronic myeloid leukemia 2011: Successes, challenges, and strategies—Proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshop

Tariq I. Mughal, Jerald P. Radich, Richard A. Van Etten, Alfonso Quintás-Cardama, Tomasz Skorski, Farhad Ravandi, Daniel J. DeAngelo, Carlo Gambacorti-Passerini, Giovanni Martinelli, Ayalew Tefferi

Journal:

American Journal of Hematology

Year:

2011

Language:

english

File:

PDF, 148 KB

english, 2011

2

Pregnancy outcomes in patients treated with bosutinib

Cortes, Jorge E, Gambacorti-Passerini, Carlo, Deininger, Michael, Abruzzese, Elisabetta, DeAnnuntis, Liza, BrÃ¼mmendorf, Tim H

Journal:

International Journal of Hematologic Oncology

Year:

2020

File:

PDF, 290 KB

2020

3

Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts

Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D., Pellagatti, A., Wainscoat, J.S., Hellstrom-Lindberg, E., Gambacorti-Passerini, C., Godfrey, A.L., Rapado, I., Cvejic,

Journal:

Boston Medical and Surgical Journal

Year:

2011

Language:

english

File:

PDF, 865 KB

english, 2011

4

10.1038/20061

Gambacorti-Passerini, Carlo

Journal:

Year:

1999

Language:

english

File:

PDF, 105 KB

english, 1999

5

Part I: Milestones in personalised medicine—imatinib

Carlo Gambacorti-Passerini

Journal:

The Lancet Oncology

Year:

2008

Language:

english

File:

PDF, 76 KB

english, 2008

6

Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia

Kantarjian, Hagop, Sawyers, Charles, Hochhaus, Andreas, Guilhot, Francois, Schiffer, Charles, Gambacorti-Passerini, Carlo, Niederwieser, Dietger, Resta, Debra, Capdeville, Renaud, Zoellner, Ulrike, Ta

Journal:

Boston Medical and Surgical Journal

Year:

2002

Language:

english

File:

PDF, 173 KB

english, 2002

7

Structural Insights into the ATP Binding Pocket of the Anaplastic Lymphoma Kinase by Site-Directed Mutagenesis, Inhibitor Binding Analysis, and Homology Modeling

Gunby, Rosalind H., Ahmed, Shaheen, Sottocornola, Roberta, Gasser, Marc, Redaelli, Sara, Mologni, Luca, Tartari, Carmen J, Belloni, Valentina, Gambacorti-Passerini, Carlo, Scapozza, Leonardo

Journal:

Journal of Medicinal Chemistry

Year:

2006

Language:

english

File:

PDF, 897 KB

english, 2006

8

In vivo activation of lymphocytes in melanoma patients receiving escalating doses of recombinant interleukin 2

Carlo Gambacorti-Passerini, Marina Radrizzani, Raffaele Marolda, Filiberto Belli, Gianalfredo Sciorelli, Andrew R. Galazka, John D. Schindler, Natale Cascinelli, Giorgio Parmiani

Journal:

International Journal of Cancer

Year:

1988

Language:

english

File:

PDF, 705 KB

english, 1988

9

Synergistic activity of the Src/Abl inhibitor bosutinib in combination with imatinib

Redaelli, S, Boschelli, F, Perini, P, Pirola, A, Viltadi, M, Gambacorti-Passerini, C

Journal:

Year:

2010

Language:

english

File:

PDF, 324 KB

english, 2010

10

Immune response to autologous human melanoma: implication of class I and II MHC products

G. Fossati, Anichini A., D. Taramelli, A. Balsari, C. Gambacorti-Passerini, J.M. Kirkwood, G. Parmiani

Journal:

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer

Year:

1986

Language:

english

File:

PDF, 1.39 MB

english, 1986

11

Lack of T-cell-mediated recognition of the fusion region of the pml/RAR-$\alpha$ hybrid protein by lymphocytes of acute promyelocytic leukemia patients

Dermime, Said, Bertazzoli, Carla, Marchesi, Edoardo, Ravagnani, Fernando, Blaser, Kurt, Corneo, Gian Marco, Pogliani, Enrico, Parmiani, Giorgio, Gambacorti-Passerini, Carlo

Journal:

Clinical Cancer Research

Year:

1996

Language:

english

File:

PDF, 1.38 MB

english, 1996

12

Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea

Renso, Rossella, Aroldi, Andrea, Pioltelli, Pietro, Gambacorti-Passerini, Carlo, Elli, Elena Maria

Journal:

Blood Cancer Journal

Year:

2018

Language:

english

File:

PDF, 297 KB

english, 2018

13

Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the pml/RAR alpha protein

Dermime, S, Grignani, F, Clerici, M, Nervi, C, Sozzi, G, Talamo, GP, Marchesi, E, Formelli, F, Parmiani, G, Pelicci, PG, Gambacorti-Passerini, C

Journal:

Year:

1993

File:

PDF, 1.47 MB

1993

14

BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2

Perrotti, Danilo, Cesi, Vincenzo, Trotta, Rossana, Guerzoni, Clara, Santilli, Giorgia, Campbell, Kenneth, Iervolino, Angela, Condorelli, Fabrizio, Gambacorti-Passerini, Carlo, Caligiuri, Michael A.

Journal:

Nature Genetics

Year:

2002

Language:

english

File:

PDF, 1013 KB

english, 2002

15

A rapid method for the purification of wild-type and V804M mutant ret catalytic domain: A tool to study thyroid cancer

Elisa Sala, Luca Mologni, Sara Cazzaniga, Elena Papinutto, Carlo Gambacorti-Passerini

Journal:

International Journal of Biological Macromolecules

Year:

2006

Language:

english

File:

PDF, 322 KB

english, 2006

16

Chronic myeloid leukemia: reminiscences and dreams

Mughal, T. I., Radich, J. P., Deininger, M. W., Apperley, J. F., Hughes, T. P., Harrison, C. J., Gambacorti-Passerini, C., Saglio, G., Cortes, J., Daley, G. Q.

Journal:

Year:

2016

Language:

english

File:

PDF, 2.74 MB

english, 2016

17

In vitro transcription and translation inhibition by anti-promyelocytic leukemia (PML)/retinoic acid receptor alpha and anti-PML peptide nucleic acid

Gambacorti-Passerini, C, Mologni, L, Bertazzoli, C, le Coutre, P, Marchesi, E, Grignani, F, Nielsen, PE

Journal:

Year:

1996

File:

PDF, 2.78 MB

1996

18

Oncogenic protein tyrosine kinases

C. Gambacorti-Passerini

Journal:

Cellular and Molecular Life Sciences

Year:

2004

Language:

english

File:

PDF, 58 KB

english, 2004

19

Corrigendum: In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate'

Gambacorti-Passerini, Carlo, Tornaghi, Lucia, Franceschino, Anna, Piazza, Rocco, Corneo, Gianmarco, Pogliani, Enrico

Journal:

Nature Medicine

Year:

2007

File:

PDF, 43 KB

2007

20

Phenotypic and functional analysis of lymphocytes infiltrating paediatric tumours, with a characterization of the tumour phenotype

Licia Rivoltini, Flavio Arienti, Attilio Orazi, Graziella Cefalo, Marco Gasparini, Carlo Gambacorti-Passerini, Franca Fossati-Bellani, Giorgio Parmiani

Journal:

Cancer Immunology, Immunotherapy

Year:

1992

Language:

english

File:

PDF, 1.36 MB

english, 1992

21

Developments in anaplastic large-cell lymphoma: targeting the anaplastic lymphoma kinase

Gambacorti-Passerini, Carlo, Farina, Francesca, Stasia, Alessandra

Journal:

Blood and Lymphatic Cancer Targets and Therapy

Year:

2014

Language:

english

File:

PDF, 264 KB

english, 2014

22

A needle in a haystack: Identifying biomarkers to personalize systemic therapy in patients with hepatocellular carcinoma

Wege, Henning, Brümmendorf, Tim H., Gambacorti-Passerini, Carlo

Journal:

Year:

2013

Language:

english

File:

PDF, 326 KB

english, 2013

23

The Novel PIM1 Inhibitor NMS-P645 Reverses PIM1-Dependent Effects on TMPRSS2/ERG Positive Prostate Cancer Cells And Shows Anti-Proliferative Activity in Combination with PI3K Inhibition

Mologni, Luca, Magistroni, Vera, Casuscelli, Francesco, Montemartini, Marisa, Gambacorti-Passerini, Carlo

Journal:

Journal of Cancer

Year:

2017

Language:

english

File:

PDF, 832 KB

english, 2017

24

Primary Results of the Phase 4 BYOND Study of Bosutinib for Pretreated Chronic Phase (CP) Chronic Myeloid Leukemia (CML)

Gambacorti-Passerini, Carlo, Abboud, Camille, Gjertsen, Bjørn Tore, Brümmendorf, Tim, Smith, B. Douglas, Giraldo-Castellano, Pilar, Strömberg, Ulla, Saussele, Susanne, Bardy-Bouxin, Nathalie, Viqueira

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

Language:

english

File:

PDF, 68 KB

english, 2019

25

Abl inhibitor BMS354825 binding mode in Ableson kinase revealed by molecular docking studies

Gambacorti-Passerini, C, Gasser, M, Ahmed, S, Scapozza, L

Journal:

Year:

2005

File:

PDF, 95 KB

2005

26

The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with Imatinib mesylate predicts for prolonged response at 6 years

Rocco G. Piazza, Vera Magistroni, Anna Franceschino, Federica Andreoni, Lucia Tornaghi, Federica Colnaghi, Gianmarco Corneo, Enrico M. Pogliani, Carlo Gambacorti-Passerini

Journal:

Blood Cells, Molecules, and Diseases

Year:

2006

Language:

english

File:

PDF, 111 KB

english, 2006

27

Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias

Carlo B Gambacorti-Passerini, Rosalind H Gunby, Rocco Piazza, Annamaria Galietta, Roberta Rostagno, Leonardo Scapozza

Journal:

The Lancet Oncology

Year:

2003

Language:

english

File:

PDF, 2.07 MB

english, 2003

28

Current management of CML patients: Summary of the Italian Consensus Meeting held in Rome, April 11–12, 2013

Breccia, Massimo, Alimena, Giuliana, Baccarani, Michele, Bocchia, Monica, Di Raimondo, Francesco, Gambacorti-Passerini, Carlo, Gozzini, Antonella, Morra, Enrica, Pane, Fabrizio, Pregno, Patrizia, Rege

Journal:

Critical Reviews in Oncology/Hematology

Year:

2014

Language:

english

File:

PDF, 580 KB

english, 2014

29

Activity of Bosutinib, Dasatinib, and Nilotinib Against 18 Imatinib-Resistant BCR/ABL Mutants

Redaelli, S., Piazza, R., Rostagno, R., Magistroni, V., Perini, P., Marega, M., Gambacorti-Passerini, C., Boschelli, F.

Journal:

Journal of Clinical Oncology

Year:

2008

Language:

english

File:

PDF, 207 KB

english, 2008

30

Focal Adhesion Kinase (FAK) Binds RET Kinase via Its FERM Domain, Priming a Direct and Reciprocal RET-FAK Transactivation Mechanism

Plaza-Menacho, I., Morandi, A., Mologni, L., Boender, P., Gambacorti-Passerini, C., Magee, A. I., Hofstra, R. M. W., Knowles, P., McDonald, N. Q., Isacke, C. M.

Journal:

Journal of Biological Chemistry

Year:

2011

Language:

english

File:

PDF, 2.98 MB

english, 2011

31

A Phase II Study of the Administration of Recombinant Interleukin 2 (rIL-2) Plus Lymphokine Activated Killer (LAK) Cells in Stage IV Melanoma Patients

Cascinelli, Natale, Belli, Filiberto, Marchini, Silvana, Marolda, Raffaele, Prada, Augusto, Sciorelli, Gianalfredo, Villani, Fabrizio, Gambacorti-Passerini, Carlo, Galazka, Andrew, Parmiani, Giorgio

Journal:

Year:

1989

Language:

english

File:

PDF, 1.35 MB

english, 1989

32

Inhibitors of the RET tyrosine kinase based on a 2-(alkylsulfanyl)-4-(3-thienyl)nicotinonitrile scaffold

Wiebke Brandt, Luca Mologni, Lutz Preu, Thomas Lemcke, Carlo Gambacorti-Passerini, Conrad Kunick

Journal:

European Journal of Medicinal Chemistry

Year:

2010

Language:

english

File:

PDF, 665 KB

english, 2010

33

Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases

Spinelli, Roberta, Pirola, Alessandra, Redaelli, Sara, Sharma, Nitesh, Raman, Hima, Valletta, Simona, Magistroni, Vera, Piazza, Rocco, Gambacorti-Passerini, Carlo

Journal:

Molecular Genetics & Genomic Medicine

Year:

2013

Language:

english

File:

PDF, 2.89 MB

english, 2013

34

Treatment Efficacy and Resistance Mechanisms Using the Second-Generation ALK Inhibitor AP26113 in Human NPM-ALK-Positive Anaplastic Large Cell Lymphoma

Ceccon, M., Mologni, L., Giudici, G., Piazza, R., Pirola, A., Fontana, D., Gambacorti-Passerini, C.

Journal:

Molecular Cancer Research

Year:

2015

Language:

english

File:

PDF, 1.04 MB

english, 2015

35

Obesity in Patients with Endometrial Cancer: May It Affect the Surgical Outcomes of Laparoscopic Approach?

Gambacorti-Passerini, Z. M., López-De la Manzanara Cano, C., Pérez Parra, C., Cespedes Casas, M. C., Sánchez Hipólito, L., Martín Francisco, C., Muñoz-Rodríguez, J. R.

Journal:

Obesity Surgery

Year:

2019

Language:

english

File:

PDF, 277 KB

english, 2019

36

PF415 EFFICACY AND SAFETY FOLLOWING DOSE REDUCTION OF BOSUTINIB IN PREVIOUSLY TREATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA: ANALYSIS OF THE PHASE 4 BYOND TRIAL

BrÃ¼mmendorf, T.H., Giles, F., Gambacorti-Passerini, C., Roboz, G.J., Le Coutre, P., Hjorth-Hansen, H., Stenke, L., Cervantes, F., Rousselot, P., Viqueira, A., Bardy-Bouxin, N., Leip, E., Leone, J.M.,

Journal:

Year:

2019

File:

PDF, 700 KB

2019

37

Sphingosine kinase 1 overexpression is regulated by signaling through PI3K, AKT2, and mTOR in imatinib-resistant chronic myeloid leukemia cells

Gabriella Marfe, Carla Di Stefano, Alessandra Gambacurta, Tiziana Ottone, Valentina Martini, Elisabetta Abruzzese, Luca Mologni, Paola Sinibaldi-Salimei, Paolo de Fabritis, Carlo Gambacorti-Passerini,

Journal:

Experimental Hematology

Year:

2011

Language:

english

File:

PDF, 1.80 MB

english, 2011

38

Imatinib-loaded polyelectrolyte microcapsules for sustained targeting of BCR-ABL + leukemia stem cells

Palamà, Ilaria E, Leporatti, Stefano, Luca, Emanuela de, Renzo, Nicola Di, Maffia, Michele, Gambacorti-Passerini, Carlo, Rinaldi, Ross, Gigli, Giuseppe, Cingolani, Roberto, Coluccia, Addolorata ML

Journal:

Year:

2010

Language:

english

File:

PDF, 649 KB

english, 2010

39

SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations

Meggendorfer, M, Bacher, U, Alpermann, T, Haferlach, C, Kern, W, Gambacorti-Passerini, C, Haferlach, T, Schnittger, S

Journal:

Year:

2013

Language:

english

File:

PDF, 453 KB

english, 2013

40

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up

Gambacorti-Passerini, Carlo, Brümmendorf, Tim H., Kim, Dong-Wook, Turkina, Anna G., Masszi, Tamas, Assouline, Sarit, Durrant, Simon, Kantarjian, Hagop M., Khoury, H. Jean, Zaritskey, Andrey, Shen, Zhi

Journal:

American Journal of Hematology

Year:

2014

Language:

english

File:

PDF, 910 KB

english, 2014

41

Acute Promyelocytic Leukaemia Cells Resistant to Retinoic Acid Show Further Perturbation of the RARα Signal Transduction System

Dermime, Said, Grignani, Francesco, Rogaia, Daniela, Liberatore, Concetta, Marchesi, Edoardo, Gambacorti-Passerini, Carlo

Journal:

Leukemia and Lymphoma

Year:

1995

Language:

english

File:

PDF, 614 KB

english, 1995

42

An Observational Study of Survival in Patients with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) After 1, 3, and 5 Years of Tyrosine Kinase Inhibitor (TKI) Therapy (SIMPLICITY)

Michallet, Mauricette, Cortes, Jorge, Gambacorti-Passerini, Carlo, Hehlmann, Rüdiger, Williams, Loretta A., Goldberg, Stuart L., Davis, Catherine, De Solda, Francesco, Sen, Ginny P., Gajavelli, Srikan

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2018

Language:

english

File:

PDF, 68 KB

english, 2018

43

Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2

Flavio Arienti, Filiberto Belli, Licia Rivoltini, Carlo Gambacorti-Passerini, Luigi Furlan, Luigi Mascheroni, Augusto Prada, Maurilia Rizzi, Edoardo Marchesi, Maurizio Vaglini, Giorgio Parmiani, Natal

Journal:

Cancer Immunology, Immunotherapy

Year:

1993

Language:

english

File:

PDF, 890 KB

english, 1993

44

Inhibition of the ABL Kinase Activity Blocks the Proliferation of BCR/ABL+Leukemic Cells and Induces Apoptosis

Carlo Gambacorti-Passerini, Philipp le Coutre, Luca Mologni, Mirco Fanelli, Carla Bertazzoli, Edoardo Marchesi, Massimo Di Nicola, Andrea Biondi, Gian Marco Corneo, Daniela Belotti, Enrico Pogliani, N

Journal:

Blood Cells, Molecules, and Diseases

Year:

1997

Language:

english

File:

PDF, 239 KB

english, 1997

45

Reply to P. Laneuville et al

Gambacorti-Passerini, C., Piazza, R., Perini, P., Rostagno, R., Redaelli, S.

Journal:

Journal of Clinical Oncology

Year:

2010

Language:

english

File:

PDF, 49 KB

english, 2010

46

Sorafenib Functions to Potently Suppress RET Tyrosine Kinase Activity by Direct Enzymatic Inhibition and Promoting RET Lysosomal Degradation Independent of Proteasomal Targeting

Plaza-Menacho, I., Mologni, L., Sala, E., Gambacorti-Passerini, C., Magee, A. I., Links, T. P., Hofstra, R. M. W., Barford, D., Isacke, C. M.

Journal:

Journal of Biological Chemistry

Year:

2007

Language:

english

File:

PDF, 1.06 MB

english, 2007

47

Chronic myeloid leukemia: Second-line drugs of choice

Gambacorti-Passerini, Carlo, Aroldi, Andrea, Cordani, Nicoletta, Piazza, Rocco

Journal:

American Journal of Hematology

Year:

2016

Language:

english

File:

PDF, 430 KB

english, 2016

48

Patient-reported outcomes in the phase 3 BFORE trial of bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia

Cortes, Jorge E., Gambacorti-Passerini, Carlo, Deininger, Michael W., Mauro, Michael J., Chuah, Charles, Kim, Dong-Wook, Milojkovic, Dragana, le Coutre, Philipp, Garcia-Gutierrez, Valentin, Crescenzo,

Journal:

Journal of Cancer Research and Clinical Oncology

Year:

2019

Language:

english

File:

PDF, 790 KB

english, 2019

49

Constitutive Degradation of PML/RARî Through the Proteasome Pathway Mediates Retinoic Acid Resistance

Fanelli, Mirco, Minucci, Saverio, Gelmetti, Vania, Nervi, Clara, Gambacorti-Passerini, Carlo, Pelicci, Pier Giuseppe

Journal:

Year:

1999

File:

PDF, 271 KB

1999

50

DOSING PATTERNS OF DASATINIB AND NILOTINIB USE IN SIMPLICITY, AN OBSERVATIONAL STUDY IN CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS (PTS) IN ROUTINE CLINICAL PRACTICE

Cortes, J., Gambacorti-Passerini, C., Goldberg, S., Mauro, M., Chen, C., Davis, C.

Journal:

Year:

2019

File:

PDF, 773 KB

2019

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски